Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,979,600 | 1,810,100 | 2,560,800 | 2,707,900 | 2,780,000 |
| Depreciation Amortization | 726,400 | 597,500 | 548,500 | 493,000 | 454,900 |
| Income taxes - deferred | -347,500 | 772,400 | 130,900 | 346,500 | 273,800 |
| Accounts receivable | -286,400 | -240,800 | -195,100 | -321,100 | 167,500 |
| Accounts payable and accrued liabilities | -1,463,400 | -173,400 | 661,600 | -268,500 | 20,400 |
| Other Working Capital | -1,947,100 | -1,291,000 | 83,800 | -1,542,100 | -77,400 |
| Other Operating Activity | 3,252,000 | 1,394,700 | -143,800 | 655,000 | 42,400 |
| Operating Cash Flow | $1,913,600 | $2,869,500 | $3,646,700 | $2,070,700 | $3,661,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 62,700 | -1,119,000 | 774,000 | -651,800 | -520,300 |
| PPE Investments | -1,287,000 | -1,877,600 | -1,645,400 | -1,094,100 | -852,400 |
| Net Acquisitions | N/A | -71,700 | N/A | N/A | N/A |
| Purchase Of Investment | -1,183,100 | -11,967,700 | -7,005,300 | -5,190,300 | -5,931,100 |
| Sale Of Investment | 545,100 | 14,849,300 | 6,762,400 | 4,777,900 | 3,708,700 |
| Other Investing Activity | -353,600 | -498,100 | -217,200 | -316,100 | -369,700 |
| Investing Cash Flow | $-2,215,900 | $-684,800 | $-1,331,500 | $-2,474,400 | $-3,964,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,988,700 | 1,478,200 | -247,300 | -18,000 | 102,000 |
| Debt Issued | 3,000,000 | 1,000,000 | 830,000 | 1,259,600 | 901,300 |
| Debt Repayment | -1,004,700 | -839,200 | -540,000 | -7,200 | -408,600 |
| Common Stock Issued | 105,900 | 117,900 | 99,300 | 64,600 | 109,500 |
| Common Stock Repurchased | -377,900 | N/A | -276,800 | -385,200 | -545,700 |
| Dividend Paid | -1,654,900 | -1,539,800 | -1,443,000 | -1,335,800 | -1,207,200 |
| Other Financing Activity | 39,800 | -13,400 | -500 | 0 | 0 |
| Financing Cash Flow | $-1,880,500 | $203,700 | $-1,578,300 | $-422,000 | $-1,048,700 |
| Exchange Rate Effect | -175,800 | 220,600 | 73,500 | 69,300 | -60,700 |
| Beginning Cash Position | 5,365,300 | 2,756,300 | 1,945,900 | 2,702,300 | 4,114,900 |
| End Cash Position | 3,006,700 | 5,365,300 | 2,756,300 | 1,945,900 | 2,702,300 |
| Net Cash Flow | $-2,358,600 | $2,609,000 | $810,400 | $-756,400 | $-1,412,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,913,600 | 2,869,500 | 3,646,700 | 2,070,700 | 3,661,600 |
| Capital Expenditure | -1,298,100 | -1,898,100 | -1,706,600 | -1,130,900 | -884,000 |
| Free Cash Flow | 615,500 | 971,400 | 1,940,100 | 939,800 | 2,777,600 |